Solas-Zubiaurre, M. (., Vela-Lumbreras, S. (., Smerdou-Picazo, C. (., Martisova, E. (., Martinez-Valbuena, I. (., Luquin-Piudo, M. (. R., & Ramírez-Gil, M. (. J. (2023). JNK Activation in Alzheimer's Disease Is Driven by Amyloid β and Is Associated with Tau Pathology.
Citación estilo ChicagoSolas-Zubiaurre, M. (Maite)|||/items/8cb01e14-a547-4965-8066-dfdacaec4544, S. (Silvia)|||/items/6ac9323d-8d59-462d-88ca-f1757dec864c Vela-Lumbreras, C. (Cristian)|||/items/48fd1bd4-6483-45c9-9951-8a1b04873227 Smerdou-Picazo, E. (Eva)|||/items/80cb8569-6236-4f78-b528-c3d5bfc8efde Martisova, I. (Iván)|||/items/79d0de00-7956-4ee5-9970-6fd29db3e40c Martinez-Valbuena, M.R. (María Rosario)|||/items/6449c359-8b33-4ca4-9ff1-ca1505be7ed3 Luquin-Piudo, y M.J. (María Javier)|||/items/2d48ae79-411f-45a1-bd65-bbee2aa118da Ramírez-Gil. JNK Activation in Alzheimer's Disease Is Driven By Amyloid β and Is Associated With Tau Pathology. 2023.
Cita MLASolas-Zubiaurre, M. (Maite)|||/items/8cb01e14-a547-4965-8066-dfdacaec4544, et al. JNK Activation in Alzheimer's Disease Is Driven By Amyloid β and Is Associated With Tau Pathology. 2023.